Clinical Trial

To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .

Name: To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets . — clinical trial record (NCT07534176)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Drug-Drug Interaction Study to Evaluate the Effect of Smoking (CYP1A2 Inducer) on the Pharmacokinetics Following a Single Oral Dose of GS1-144 Tablets in Chinese Healthy Postmenopausal Female Trial Participants

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-28

Trial Details

NCT Number	NCT07534176
Lead Sponsor	Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions	Postmenopause
Enrollment	24 participants
Start Date	2026-05-20
Primary Completion	2026-10-20 (estimated)
Study Completion	2027-02-08 (estimated)
Updated on ClinicalTrials.gov	2026-05-27